Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Joven J, Menendez JA.

Cell Cycle. 2010 Nov 15;9(22):4461-8. Epub 2010 Nov 15.

PMID:
21088486
2.

Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Tan EJ, Olsson AK, Moustakas A.

Cell Adh Migr. 2015;9(3):233-46. doi: 10.4161/19336918.2014.983794. Epub 2014 Nov 17. Review.

3.

TGF-β signaling and epithelial-mesenchymal transition in cancer progression.

Katsuno Y, Lamouille S, Derynck R.

Curr Opin Oncol. 2013 Jan;25(1):76-84. doi: 10.1097/CCO.0b013e32835b6371. Review.

PMID:
23197193
4.

TGFβ and matrix-regulated epithelial to mesenchymal transition.

Moustakas A, Heldin P.

Biochim Biophys Acta. 2014 Aug;1840(8):2621-34. doi: 10.1016/j.bbagen.2014.02.004. Epub 2014 Feb 18. Review.

5.
6.

Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition.

Nalluri SM, O'Connor JW, Gomez EW.

Cytoskeleton (Hoboken). 2015 Nov;72(11):557-69. doi: 10.1002/cm.21263. Epub 2015 Dec 9. Review.

PMID:
26543012
7.

Metformin: multi-faceted protection against cancer.

Del Barco S, Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, Martin-Castillo B, Menendez JA.

Oncotarget. 2011 Dec;2(12):896-917. Review.

8.

Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.

Fuxe J, Vincent T, Garcia de Herreros A.

Cell Cycle. 2010 Jun 15;9(12):2363-74. Epub 2010 Jun 15. Review.

PMID:
20519943
9.

[The role of TGF-β-related signal transduction pathways in pathogenesis of epithelial-mesenchymal transition as a key element in cancer development and progression].

Pieniążek M, Donizy P, Ziętek M, Szynglarewicz B, Matkowski R.

Postepy Hig Med Dosw (Online). 2012 Sep 7;66:583-91. Review. Polish.

10.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA.

Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789. Review.

11.

Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.

Wendt MK, Tian M, Schiemann WP.

Cell Tissue Res. 2012 Jan;347(1):85-101. doi: 10.1007/s00441-011-1199-1. Epub 2011 Jun 21. Review.

12.

Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition.

Derynck R, Muthusamy BP, Saeteurn KY.

Curr Opin Cell Biol. 2014 Dec;31:56-66. doi: 10.1016/j.ceb.2014.09.001. Epub 2014 Sep 18. Review.

13.

Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Tan AR, Alexe G, Reiss M.

Breast Cancer Res Treat. 2009 Jun;115(3):453-95. doi: 10.1007/s10549-008-0184-1. Epub 2008 Oct 9. Review.

14.

Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract.

Lovicu FJ, Shin EH, McAvoy JW.

Exp Eye Res. 2016 Jan;142:92-101. doi: 10.1016/j.exer.2015.02.004. Epub 2015 May 21. Review.

15.

Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study.

Hugo HJ, Kokkinos MI, Blick T, Ackland ML, Thompson EW, Newgreen DF.

Cells Tissues Organs. 2011;193(1-2):23-40. doi: 10.1159/000320174. Epub 2010 Nov 2. Review.

PMID:
21051859
16.

Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

Ye X, Weinberg RA.

Trends Cell Biol. 2015 Nov;25(11):675-86. doi: 10.1016/j.tcb.2015.07.012. Epub 2015 Oct 1. Review.

17.

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer.

Jordan NV, Johnson GL, Abell AN.

Cell Cycle. 2011 Sep 1;10(17):2865-73. Epub 2011 Sep 1. Review.

18.

Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity.

Drasin DJ, Robin TP, Ford HL.

Breast Cancer Res. 2011;13(6):226. doi: 10.1186/bcr3037. Epub 2011 Nov 1. Review.

19.

The relevance of the TGF-β Paradox to EMT-MET programs.

Morrison CD, Parvani JG, Schiemann WP.

Cancer Lett. 2013 Nov 28;341(1):30-40. doi: 10.1016/j.canlet.2013.02.048. Epub 2013 Mar 5. Review.

20.

Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells.

Kim YS, Yi BR, Kim NH, Choi KC.

Exp Mol Med. 2014 Aug 1;46:e108. doi: 10.1038/emm.2014.44. Review.

Supplemental Content

Support Center